| Net Cash Provided by (Used in) Operating Activities |
$646,000 |
USD |
504% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$1,674,000 |
USD |
-885% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$976,000 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q4 2025 |
Q3 2026 |
| Common Stock, Shares, Issued |
10,011,332 |
shares |
3.6% |
Q4 2025 |
Q3 2026 |
| Common Stock, Par or Stated Value Per Share |
0.0001 |
USD/shares |
0% |
Q4 2025 |
Q3 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$52,000 |
USD |
45% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$50,000 |
USD |
-70% |
Q4 2025 |
Q3 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$110,000 |
USD |
-5.2% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$6,000,000 |
USD |
-3.2% |
Q4 2025 |
Q3 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Gross |
$7,467,000 |
USD |
-8.8% |
Q1 2025 |
FY 2025 |
| Operating Lease, Liability |
$3,832,000 |
USD |
-16% |
Q4 2025 |
Q3 2026 |
| Depreciation |
$514,000 |
USD |
-2.1% |
Q4 2025 |
Q3 2026 |
| Payments to Acquire Property, Plant, and Equipment |
$1,250,000 |
USD |
522% |
Q2 2025 |
Q1 2026 |
| Property, Plant and Equipment, Gross |
$29,264,000 |
USD |
|
Q4 2025 |
Q3 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.045 |
pure |
0% |
Q4 2025 |
Q3 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,056,000 |
USD |
-3.9% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q1 2025 |
FY 2025 |
| Operating Lease, Payments |
$235,000 |
USD |
0% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
$19,369,000 |
USD |
5.5% |
Q4 2025 |
Q3 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q1 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$701,000 |
USD |
1% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,745,000 |
USD |
-39% |
Q1 2025 |
FY 2025 |